Dyadic International (DYAI) Gross Profit (QoQ) (2018 - 2025)
Powered by 
Analysis
Dyadic International (DYAI) Gross Profit (QoQ) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.70 Bn | 192.71 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.18 Bn | 177.00 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.42 Bn | 1.37 Bn |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.46 Bn | 30.15 Bn | 992.69 Mn |
| 8 | Biogen | 31.82 Bn | 30.54 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.10 Bn | 29.10 Bn | 1.16 Mn |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -79.35% |
| Dec 31, 2024 | -70.25% |
| Sep 30, 2024 | 1,760.38% |
| Jun 30, 2024 | -55.97% |
| Mar 31, 2024 | -43.33% |
| Dec 31, 2023 | 15.53% |
| Sep 30, 2023 | 558.58% |
| Jun 30, 2023 | -82.39% |
| Mar 31, 2023 | 540.08% |
| Dec 31, 2022 | -85.82% |
| Sep 30, 2022 | 11.84% |
| Jun 30, 2022 | 1.54% |
| Mar 31, 2022 | 1,428.83% |
| Dec 31, 2021 | -106.10% |
| Sep 30, 2021 | 179.20% |
| Jun 30, 2021 | -99.85% |
| Mar 31, 2021 | 77,119.74% |
| Dec 31, 2020 | -39.55% |
| Sep 30, 2020 | 249.48% |
| Jun 30, 2020 | -368.81% |